|Company:||Catalina Marketing Corporation|
|Class Period:||April 18, 2002 through October 1, 2002|
|Court:||Middle District, FL|
|Lead Plaintiff Deadline:||Sep-29-03|
The complaint alleges that defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 promulgated thereunder, by issuing numerous positive statements concerning the Company's ability to grow its revenues and earnings at a rapid pace and the strong demand that existed for the Company's products, especially at its Health Resource division. In truth and in fact, however, the Company was experiencing a slowdown in its revenue growth because its pharmaceutical clients had curtailed their spending on promotional items, such as the Company's newsletters, and retail pharmacies had become more cautious about participating in the Company's advertising programs and had reduced their distribution of the Company's health newsletters. When these facts were belatedly disclosed by the Company on October 1, 2002, the price of Catalina common stock fell from $27.97 per share to close at $17.90 per share -- a drop of 36% -- on extremely heavy trading volume.
If you acquired the securities of Catalina Marketing Corporation during the Class Period you may, no later than September 29, 2003, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.
If you feel you qualify for damages or remedies that might be awarded in this class action please fill in our form on the right to submit your complaint.
If your injustice does not match the complaint described above, please use this form to register your complaint. Thank you.